![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0229.png)
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
German language Session
Q&A Modul
SCIENTIFIC PROGRAMME
225
PR-08
Presidential Symposium
10:00– 11:30
|
Hall A3
TOPIC 9:
Comorbidity of somatic and mental disorders,
psychosomatics
Comorbidity of mental and physical diseases:
moving towards an integration of psychiatry into
medicine
Chairs:
Norman Sartorius, Switzerland
Paul Summergrad, USA
001
Understanding co-morbidity: results from the
international prevalence and treatment of diabetes
and depression (INTERPRET-DD) study
Cathy Lloyd, United Kingdom
002
Comorbidity – approaching integrity of psychi-
atry in clinical medicine
Nikolai Kornetov, Russia
003
The burden of medical psychiatric comorbidity
– a global issue
Paul Summergrad, USA
004
The easy and the difficult of doing medical
psychiatric comorbidity studies in China (part 1)
Wei Jing, People's Republic of China
005
The easy and the difficult of doing medical
psychiatric comorbidity studies in China (part 2)
Xin Yu, People's Republic of China
ST-28 (d)
State-of-the-Art-Symposium
10:00– 11:30
|
Hall A6 /A7
TOPIC 7:
Personality disorders
Borderline-Persönlichkeitsstörungen
Chairs:
Martin Bohus, Germany
Klaus Lieb, Germany
001
Epidemiologie, Ätiologie und Diagnostik der
Borderline-Persönlichkeitsstörung
Martin Bohus, Germany
002
Evidenzbasierte Psycho- und Pharmakotherapie
der Borderline-Persönlichkeitsstörung
Klaus Lieb, Germany
ST-29 (d)
State-of-the-Art-Symposium
10:00– 11:30
|
Hall A4
TOPIC 9:
Comorbidity of somatic and mental disorders,
psychosomatics
Psychosomatische Aspekte in der Behandlung
der Adipositas
Chairs:
Stephan Herpertz, Germany
Stephan Zipfel, Germany
001
Psychosomatische Aspekte der Adipositas unter
besonderer Berücksichtigung der Adipositas-Chirurgie
Stephan Herpertz, Germany
002
Psychotherapie und Verhaltensmodifikation bei
der Adipositas
Stephan Zipfel, Germany
S-362
Symposium
10:00– 11:30
|
Hall A1
TOPIC 3:
Psychotic disorders
Autoimmune encephalitis and NMDA-receptor
antibodies in schizophrenia: current knowledge and
future perspectives
Chairs:
Johann Steiner, Germany
Peter Falkai, Germany
001
Diagnostic and therapeutic dilemmas inherent
to neuropsychiatric disorders associated with neu-
roinflammation or autoimmune dysfunction
Souhel Najjar, USA
002
Antineuronal antibodies against neurotransmit-
ter receptors and synaptic proteins in schizophrenia
Johann Steiner, Germany
Thomas Frodl, Bernhard Bogerts
003
Neurocognitive phenotype and imaging abnor-
malities of patients with NMDAR antibodies
Carsten Finke, Germany
004
The diagnosis and management of autoimmune
encephalitis in psychiatric settings
Belinda Lennox, United Kingdom
S-363
Symposium
10:00– 11:30
|
Hall A2
TOPIC 32:
Violence and trauma
Refugee women are at risk
›
WPA Section: Transcultural Psychiatry
Chairs:
Meryam Schouler-Ocak, Germany
Helen Herrman, Australia
001
Gender and trauma
Inci User, Turkey